Bo-Feng Yin1,2, Zhi-Ling Li1,2, Zi-Qiao Yan1,2,3, Zheng Guo1,2,3,4, Jia-Wu Liang1,2,3,4, Qian Wang1,2,3,4, Zhi-Dong Zhao1,2,3,4, Pei-Lin Li1,2, Rui-Cong Hao1,2,5, Meng-Yue Han1,2,5, Xiao-Tong Li1,2, Ning Mao6, Li Ding7,8, Da-Fu Chen9, Yue Gao10, Heng Zhu11,12,13,14. 1. Beijing Institute of Radiation Medicine, Road Taiping 27, Beijing, 100850, People's Republic of China. 2. Beijing Key Laboratory for Radiobiology, Beijing Institute of Radiation Medicine, Beijing, 100850, People's Republic of China. 3. People's Liberation Army General Hospital, Road Fuxing 28, Beijing, 100853, People's Republic of China. 4. Medical Center of Air Forces, PLA, Road Fucheng 30, Beijing, 100142, People's Republic of China. 5. Graduate School of Anhui Medical University, 81 Meishan Road, Shushan Qu, Hefei, 230032, Anhui, People's Republic of China. 6. Beijing Institute of Basic Medical Sciences, Road Taiping 27, Beijing, 100850, People's Republic of China. 7. Beijing Institute of Radiation Medicine, Road Taiping 27, Beijing, 100850, People's Republic of China. dingli7578@163.com. 8. Medical Center of Air Forces, PLA, Road Fucheng 30, Beijing, 100142, People's Republic of China. dingli7578@163.com. 9. Laboratory of Bone Tissue Engineering, Beijing Laboratory of Biomedical Materials, Beijing Research Institute of Traumatology and Orthopaedics, Beijing Jishuitan Hospital, Eastern Street Xinjiekou 31, Beijing, 100035, China. chendafugo@aliyun.com. 10. Beijing Institute of Radiation Medicine, Road Taiping 27, Beijing, 100850, People's Republic of China. gaoyue@bmi.ac.cn. 11. Beijing Institute of Radiation Medicine, Road Taiping 27, Beijing, 100850, People's Republic of China. zhudingdingabc@163.com. 12. Beijing Key Laboratory for Radiobiology, Beijing Institute of Radiation Medicine, Beijing, 100850, People's Republic of China. zhudingdingabc@163.com. 13. Graduate School of Anhui Medical University, 81 Meishan Road, Shushan Qu, Hefei, 230032, Anhui, People's Republic of China. zhudingdingabc@163.com. 14. Beijing Institute of Basic Medical Sciences, Road Taiping 27, Beijing, 100850, People's Republic of China. zhudingdingabc@163.com.
Correction to: Stem Cell Research & Therapy (2022) 13:241 10.1186/s13287-022-02911-2
Following publication of the original article [1], the authors have identified that the incorrect image of micro-CT scanning for normal group in Fig. 1a was included due to an error during figure preparation. The corrected image of micro-CT scanning for normal group has been updated in Fig. 1a. Therefore, the revised Fig. 1 is given in this article.
Fig. 1
Psoralen mitigated irradiation-induced osteoporosis in a murine model. For the prevention/treatment group, C57BL/6 N mice (n = 5 per group) were administered psoralen (20 mg/Kg) intragastrically every day for 1 week before/after radiation and killed 1 week after radiation. The representative MicroCT data of femur bones at week 1 post-irradiation are shown in a and b. The results of BV/TV, Tb.Sp, Tb.Th, and Tb.N demonstrated that irradiation induced significant destruction of the bone structures, while treatment or prevention with psoralen remarkably alleviated the bone injuries (a and b). In addition, the image of calcein double-labeling analysis and quantitative data of BFR and MAR showed that gastric administration of psoralen promoted new bone formation in irradiated mice (c and d). The HE staining data further demonstrated that psoralen treatment provided protective effects on the bone structures of irradiated mice (e). The ELISA data showed that psoralen treatment reduces the TRAP level in serum of irradiated mice (f). Gene expression analysis of TRAF6 and OCN in femurs also suggested that psoralen inhibited osteoclastogenesis while favoring osteogenesis in irradiated mice (g). Further pathological analysis showed that psoralen partially restored the irradiation induced the reduction of OCN-labeled OBs and the increase of TRAP-labeled OCs in the irradiated mice (h and i). All data are shown as the mean ± SD. **P < 0.01, *P < 0.05. The scale bars represent 2 mm (a and c), 500 μm (e), and 200 μm (h), respectively. IR: irradiation; BV/TV: bone volume per tissue volume; Tb.N: trabecular bone number; Tb.Sp: trabecular separation; Tb.Th: trabecular bone thickness; BFR: bone formation rate; MAR: mineral deposition rate; TRAP: tartrate-resistant acid phosphatase; OCN: osteocalcin; TRAF6: TNF receptor-associated factor 6; Ob.S/B.S: osteoblast surface per bone surface; Ob.N/B.Pm: number of osteoblasts per bone perimeter; Oc.S/B.S: osteoclast surface per bone surface; and Oc.N/B.Pm: number of osteoclasts per bone perimeter
Psoralen mitigated irradiation-induced osteoporosis in a murine model. For the prevention/treatment group, C57BL/6 N mice (n = 5 per group) were administered psoralen (20 mg/Kg) intragastrically every day for 1 week before/after radiation and killed 1 week after radiation. The representative MicroCT data of femur bones at week 1 post-irradiation are shown in a and b. The results of BV/TV, Tb.Sp, Tb.Th, and Tb.N demonstrated that irradiation induced significant destruction of the bone structures, while treatment or prevention with psoralen remarkably alleviated the bone injuries (a and b). In addition, the image of calcein double-labeling analysis and quantitative data of BFR and MAR showed that gastric administration of psoralen promoted new bone formation in irradiated mice (c and d). The HE staining data further demonstrated that psoralen treatment provided protective effects on the bone structures of irradiated mice (e). The ELISA data showed that psoralen treatment reduces the TRAP level in serum of irradiated mice (f). Gene expression analysis of TRAF6 and OCN in femurs also suggested that psoralen inhibited osteoclastogenesis while favoring osteogenesis in irradiated mice (g). Further pathological analysis showed that psoralen partially restored the irradiation induced the reduction of OCN-labeled OBs and the increase of TRAP-labeled OCs in the irradiated mice (h and i). All data are shown as the mean ± SD. **P < 0.01, *P < 0.05. The scale bars represent 2 mm (a and c), 500 μm (e), and 200 μm (h), respectively. IR: irradiation; BV/TV: bone volume per tissue volume; Tb.N: trabecular bone number; Tb.Sp: trabecular separation; Tb.Th: trabecular bone thickness; BFR: bone formation rate; MAR: mineral deposition rate; TRAP: tartrate-resistant acid phosphatase; OCN: osteocalcin; TRAF6: TNF receptor-associated factor 6; Ob.S/B.S: osteoblast surface per bone surface; Ob.N/B.Pm: number of osteoblasts per bone perimeter; Oc.S/B.S: osteoclast surface per bone surface; and Oc.N/B.Pm: number of osteoclasts per bone perimeter
Authors: Peter Gál; Jan Brábek; Michal Holub; Milan Jakubek; Aleksi Šedo; Lukáš Lacina; Karolína Strnadová; Petr Dubový; Helena Hornychová; Aleš Ryška; Karel Smetana Journal: Histochem Cell Biol Date: 2022-07-22 Impact factor: 2.531